Regulation of microvascular permeability by vascular endothelial growth factors*

Journal of Anatomy - Tập 200 Số 6 - Trang 581-597 - 2002
David O. Bates1, Natalia Hillman2, Bryan Williams2, Christopher R. Neal1, Tristan Pocock1
1Microvascular Research Laboratories, Department of Physiology, University of Bristol, Bristol BS2 8EJ, UK
2Cardiovascular Research Institute, University of Leicester, Leicester LE2 7LX, UK

Tóm tắt

AbstractGeneration of new blood vessels from pre‐existing vasculature (angiogenesis) is accompanied in almost all states by increased vascular permeability. This is true in physiological as well as pathological angiogenesis, but is more marked during disease states. Physiological angiogenesis occurs during tissue growth and repair in adult tissues, as well as during development. Pathological angiogenesis is seen in a wide variety of diseases, which include all the major causes of mortality in the west: heart disease, cancer, stroke, vascular disease and diabetes. Angiogenesis is regulated by vascular growth factors, particularly the vascular endothelial growth factor family of proteins (VEGF). These act on two specific receptors in the vascular system (VEGF‐R1 and 2) to stimulate new vessel growth. VEGFs also directly stimulate increased vascular permeability to water and large‐molecular‐weight proteins. We have shown that VEGFs increase vascular permeability in mesenteric microvessels by stimulation of tyrosine autophosphorylation of VEGF‐R2 on endothelial cells, and subsequent activation of phospholipase C (PLC). This in turn causes increased production of diacylglycerol (DAG) that results in influx of calcium across the plasma membrane through store‐independent cation channels. We have proposed that this influx is through DAG‐mediated TRP channels. It is not known how this results in increased vascular permeability in endothelial cells in vivo. It has been shown, however, that VEGF can stimulate formation of a variety of pathways through the endothelial cell, including transcellular gaps, vesiculovacuolar organelle formation, and fenestrations. A hypothesis is outlined that suggests that these all may be part of the same process.

Từ khóa


Tài liệu tham khảo

Abell RG, 1946, The permeability of blood capillary sprouts and newly formed blood capillaries as compared to that of older capillaries, Am. J. Physiol., 147, 231, 10.1152/ajplegacy.1946.147.2.237

10.1113/jphysiol.1993.sp019722

10.1046/j.1523-1755.2000.07718.x

10.1152/jappl.1988.64.1.308

Bates DO, 1996, Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels, Am. J. Physiol. Heart Circulatory Physiol., 271, H2520, 10.1152/ajpheart.1996.271.6.H2520

Bates DO, 1997, Vascular endothelial growth factor increases microvascular permeability via a Ca2+‐dependent pathway, Am. J. Physiol. Heart Circulatory Physiol., 273, H687, 10.1152/ajpheart.1997.273.2.H687

10.1111/j.1469-7793.1998.225by.x

10.1111/j.1549-8719.1999.tb00091.x

10.1111/j.1469-7793.2001.0263b.x

10.1038/361315a0

Brock TA, 1991, Tumor‐secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells, Am. J. Pathol., 138, 213

Brown LF, 1993, Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas, Am. J. Pathol., 143, 1255

10.1111/j.1365-2133.1992.tb15113.x

10.1038/86490

10.1002/aja.1000570303

10.1113/jphysiol.1988.sp016910

10.1111/j.1476-5381.1993.tb13553.x

10.1172/JCI114322

Couffinhal T, 1997, Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries, Am. J. Pathol., 150, 1673

10.3109/10739689709146786

10.3171/jns.1989.71.6.0884

10.3171/jns.1988.69.2.0254

Curry FE, 1983, Cardiovascular Physiology. Techniques in the Life Sciences, 1

Curry FE, 1984, Handbook of Physiology. The Cardiovascular System. Microcirculation, 309

10.1096/fasebj.6.7.1563597

Damert A, 1997, Up‐regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia‐driven mechanisms, Cancer Res., 57, 3860

10.1126/science.1312256

Dejana E, 2001, Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration, Thromb. Haemost., 86, 308, 10.1055/s-0037-1616228

10.1084/jem.180.3.1141

10.1006/bbrc.1999.0227

10.1002/jlb.59.1.100

10.1007/978-3-642-59953-8_6

10.1083/jcb.140.4.947

10.1016/0248-4900(91)90002-5

10.1084/jem.183.5.1981

10.1111/j.1469-7793.1997.747bd.x

10.1111/j.1549-8719.1999.tb00085.x

10.1016/0006-291X(89)92678-8

10.1097/00041552-199601000-00008

10.1152/ajpcell.2001.280.6.C1358

Fong TA, 1999, SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk‐1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types, Cancer Res., 59, 99

FuB(2001)Structural mechanism of vascular endothelial growth factor (VEGF) induced acute microvessel hyperpermeability.Proceedings of the 7th World Congress for Microcirculation. 30–5.ANZMCS Sydney.

10.1074/jbc.273.46.30336

10.1042/0264-6021:3480273

10.1074/jbc.270.12.6729

He P, 1990, Measurement of cytoplasmic calcium in single microvessels with increased permeability, Am. J. Physiol., 258, H1366

Hillman NJ, 2000, Microvessel endothelial cell ultrastructure after vascular endothelial growth factor‐C (VEGF‐C) induced chronically increased Lp, J. Vasc. Res., 38, 195

10.1159/000051044

10.1152/ajplung.1998.274.5.L678

10.1076/0271-3683(200008)2121-VFT637

10.1038/16711

10.1210/mend-5-12-1806

10.1016/S0021-9258(18)35712-0

Hudlicka O, 1984, Handbook of Physiology. The Cardiovascular System. Microcirculation, 165

10.1152/physrev.1992.72.2.369

10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.0.CO;2-7

Jingjing L, 1999, Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor, Invest. Ophthalmol. Vis. Sci., 40, 752

10.1002/j.1460-2075.1996.tb00359.x

10.1126/science.2479987

10.1074/jbc.271.10.5638

10.1074/jbc.271.13.7788

10.1152/ajpheart.1993.265.2.H586

Lakshminarayanan S, 2000, Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO, Invest. Ophthalmol. Vis. Sci., 41, 4256

Landis EM, 1963, Handbook of Physiology, Circulation, 961

10.1126/science.2479986

10.1016/0026-2862(87)90020-3

10.1182/blood.V90.6.2253.2253_2253_2259

10.1016/S0022-5223(98)70455-6

10.1083/jcb.42.3.647

10.1113/expphysiol.1974.sp002275

Michel CC, 1984, Handbook of Physiology. The Cardiovascular System. Microcirculation, 375

10.1113/jphysiol.1987.sp016622

10.1016/S0008-6363(96)00064-8

10.1152/physrev.1999.79.3.703

10.1113/jphysiol.1952.sp004789

Mukhopadhyay D, 1998, Vascular permeability factor/vascular endothelial growth factor‐mediated signaling in mouse mesentery vascular endothelium, Cancer Res., 58, 1278

10.1038/375577a0

10.1093/rheumatology/28.1.31

10.1113/expphysiol.1992.sp003659

Neal CR, 1997, Vascular endothelial growth factor (VEGF) increases permeability by inducing openings through endothelial cells, Int. J. Microcirculation: Clin. Exp., 17, 198

Neal CR, 1998, Differing effects of Vascular Endothelial Growth Factor (VEGF) on the ultrastructure of mesenteric microvessels of frog and rat, J. Physiol, 506, 24p

Neal CR, 1998, Ultrastructural changes in microvascular endothelium associated with increased permeability, J. Vasc. Res., 35, 388

Neal CR, 2001, Ferritin as a tracer when used to increase permeability in frog microvessels, J. Vasc. Res., 38, 190

Neal CR, 2002, Vascular Endothelial Growth Factor produces a greater transient increase in hydraulic permeability at lower rather than at higher capillary pressures, J. Physiol., 536

10.1096/fasebj.13.1.9

10.1006/bbrc.1999.1840

10.1074/jbc.273.7.4220

10.1016/S0021-9258(18)47298-5

10.1111/j.1469-7793.2000.t01-1-00435.x

10.1152/ajpheart.2000.279.4.H1625

Pocock T, 2001, PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptors, attenuates VEGF‐induced increases in hydraulic conductivity (Lp) in frog mesenteric microvessels in vivo, J. Physiol., 531

10.1111/j.1469-7793.2001.00479.x

Pocock TM, 2002, A diacylglycerol analogue (OAG) increases endothelial cell calcium concentration ([Ca2+]i) in frog mesenteric microvessels, in vivo

10.1074/jbc.272.11.7151

10.1016/S0021-9258(20)30073-9

10.1242/jcs.108.6.2369

10.1038/ki.1997.60

10.1007/BF00963592

Seetharam L, 1995, A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF, Oncogene, 10, 135

10.1126/science.6823562

Senger DR, 1986, A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines, Cancer Res., 46, 5629

Senger DR, 1990, Purification and NH2‐terminal amino acid sequence of guinea pig tumor‐secreted vascular permeability factor, Cancer Res., 50, 1774

10.1016/0026-2862(80)90064-3

10.1074/jbc.271.10.5761

10.1016/S0092-8674(00)81402-6

10.1159/000146344

Taylor AE, 1984, Handbook of Physiology. The Cardiovascular System. Microcirculation, 467

10.1016/0006-291X(92)90483-2

10.1016/S0021-9258(18)99049-6

10.1172/JCI8218

10.1023/A:1006453428508

10.1016/0026-2862(92)90104-W

10.1038/ki.1997.79

10.1016/S0014-5793(97)01481-6

10.1042/CS19990016

Whittles CE, 2001, ZM323881, an inhibitor of vascular endothelial growth factor receptors, attenuates VEGF‐induced increases in hydraulic conductivity (Lp) in frog mesenteric microvessels in vivo, J. Vasc. Res., 38, 409

Wood JM, 2000, PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor‐induced responses and tumor growth after oral administration, Cancer Res., 60, 2178

Wu HM, 1996, VEGF induces NO‐dependent hyperpermeability in coronary venules, Am. J. Physiol. Heart Circulatory Physiol., 271, H2735, 10.1152/ajpheart.1996.271.6.H2735

10.1074/jbc.275.7.5096

10.1152/ajpheart.1999.276.2.H535

10.1172/JCI119006

Xu L, 2000, Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, Int. J. Oncol., 16, 445

10.1172/JCI11317

Yano S, 2000, Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation, Clin. Cancer Res., 6, 957

10.1016/S0008-6363(00)00268-6